BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 28755025)

  • 21. The Search for Causative Environmental Factors in Inflammatory Bowel Disease.
    Rogler G; Zeitz J; Biedermann L
    Dig Dis; 2016; 34 Suppl 1():48-55. PubMed ID: 27548430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].
    Ochsenkühn T; Sackmann M; Göke B
    Radiologe; 2003 Jan; 43(1):1-8. PubMed ID: 12552369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory Bowel Disease: Historical Perspective, Epidemiology, and Risk Factors.
    Malik TA
    Surg Clin North Am; 2015 Dec; 95(6):1105-22, v. PubMed ID: 26596917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From Genes to Mechanisms: The Expanding Spectrum of Monogenic Disorders Associated with Inflammatory Bowel Disease.
    Uhlig HH; Schwerd T
    Inflamm Bowel Dis; 2016 Jan; 22(1):202-12. PubMed ID: 26512716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gastrointestinal manifestations in immunodeficiencies with monogenic origin].
    Veres G; Gaál Z
    Orv Hetil; 2018 Dec; 159(49):2050-2056. PubMed ID: 30525883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of focally enhanced gastritis in the diagnosis of pediatric inflammatory bowel diseases.
    Roka K; Roma E; Stefanaki K; Panayotou I; Kopsidas G; Chouliaras G
    J Crohns Colitis; 2013 Nov; 7(10):797-802. PubMed ID: 23207168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent understanding of IBD pathogenesis: implications for future therapies.
    Kucharzik T; Maaser C; Lügering A; Kagnoff M; Mayer L; Targan S; Domschke W
    Inflamm Bowel Dis; 2006 Nov; 12(11):1068-83. PubMed ID: 17075348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of very early-onset inflammatory bowel disease.
    de Mesquita MB; Shouval DS
    Curr Opin Gastroenterol; 2020 Nov; 36(6):464-469. PubMed ID: 32868508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic and Immunologic Drivers of Very Early-Onset Inflammatory Bowel Disease.
    Conrad MA; Kelsen JR
    Pediatr Dev Pathol; 2019; 22(3):183-193. PubMed ID: 30841788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis.
    Agius LM
    J Theor Biol; 2004 Mar; 227(2):219-28. PubMed ID: 14990386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A de novo whole gene deletion of XIAP detected by exome sequencing analysis in very early onset inflammatory bowel disease: a case report.
    Kelsen JR; Dawany N; Martinez A; Grochowski CM; Maurer K; Rappaport E; Piccoli DA; Baldassano RN; Mamula P; Sullivan KE; Devoto M
    BMC Gastroenterol; 2015 Nov; 15():160. PubMed ID: 26581487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammatory bowel disease in Turkish children.
    Cakir M; Unal F; Dinler G; Baran M; Yuksekkaya HA; Tumgor G; Kasirga E; Kalayci AG; Aydogdu S
    World J Pediatr; 2015 Nov; 11(4):331-7. PubMed ID: 26454438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies.
    Ouahed J; Spencer E; Kotlarz D; Shouval DS; Kowalik M; Peng K; Field M; Grushkin-Lerner L; Pai SY; Bousvaros A; Cho J; Argmann C; Schadt E; Mcgovern DPB; Mokry M; Nieuwenhuis E; Clevers H; Powrie F; Uhlig H; Klein C; Muise A; Dubinsky M; Snapper SB
    Inflamm Bowel Dis; 2020 May; 26(6):820-842. PubMed ID: 31833544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. News from the "5th International Meeting on Inflammatory Bowel Diseases" CAPRI 2010.
    Latella G; Fiocchi C; Caprili R
    J Crohns Colitis; 2010 Dec; 4(6):690-702. PubMed ID: 21122584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding inflammatory bowel disease via immunogenetics.
    de Lange KM; Barrett JC
    J Autoimmun; 2015 Nov; 64():91-100. PubMed ID: 26257098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory bowel disease.
    Jenkins HR
    Arch Dis Child; 2001 Nov; 85(5):435-7. PubMed ID: 11668114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association.
    Principi M; Cassano N; Contaldo A; Iannone A; Losurdo G; Barone M; Mastrolonardo M; Vena GA; Ierardi E; Di Leo A
    World J Gastroenterol; 2016 May; 22(20):4802-11. PubMed ID: 27239107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis.
    Eichele DD; Kharbanda KK
    World J Gastroenterol; 2017 Sep; 23(33):6016-6029. PubMed ID: 28970718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.